The key points are temporarily unavailable. You can still read the full Story below.
Main Points
Barry Tangwell, the managing director of Bryden pi, has addressed the issues surrounding the pharmaceutical sector in Trinidad and Tobago. According to Tangwell, the main problem isn't about monopoly, distribution, or pricing, but rather the representation and market involvement of different pharmaceutical brands. He asserts that access to affordable medication isn't a challenge as generic drugs are competitively priced and widely available. He further stated that the industry is in constant flux, shaped by international standards, stringent quality controls, and compliance rules.
Barry Tangwell, the managing director of Bryden pi, has addressed the issues surrounding the pharmaceutical sector in Trinidad and Tobago. According to Tangwell, the main problem isn’t about monopoly, distribution, or pricing, but rather the representation and market involvement of different pharmaceutical brands. He asserts that access to affordable medication isn’t a challenge as generic drugs are competitively priced and widely available. He further stated that the industry is in constant flux, shaped by international standards, stringent quality controls, and compliance rules.
